Device
PD cycler
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Terminated(1)
Detailed Status
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
withdrawn150%
not_yet_recruiting150%
Recent Activity
0 active trials
Showing 2 of 2
Clinical Trials (2)
Showing 2 of 2 trials
NCT06390592Not Applicable
Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony
NCT06443021Not Applicable
Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2